Table 5.
Sensitivity analysis of clinical cardiovascular risk factors.
| Change in TG (mg/dL) | Change in GLU (mg/dL) | Change in DBP (mm Hg) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | Q 1 | Q 2 | Q 3 | P a | Q 1 | Q 2 | Q 3 | P a | Q 1 | Q 2 | Q 3 | P a | |||||||||||
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | ||||||
| Gender | Male | 236 | 6.41 | 43.58 | −17.86 | 62.54 | −14.80 | 44.68 | 0.007 | 2.35 | 38.03 | −0.32 | 35.56 | −6.12 | 35.99 | 0.36 | −1.24 | 10.04 | −2.43 | 9.73 | −2.14 | 11.67 | 0.714 |
| Female | 249 | 8.22 | 46.57 | 9.25∗∗ | 53.14 | −5.01 | 68.69 | 0.194 | 10.31 | 38.68 | 9.23 | 30.44 | 1.51 | 35.04 | 0.193 | −1.46 | 10.24 | −3.67 | 10.75∗ | −5.29 | 9.84 | 0.026 | |
| Age, years | ≤67 | 242 | 8.71 | 47.80 | −9.75 | 70.39 | −8.77 | 62.27 | 0.089 | 7.08 | 41.13 | 1.56 | 30.86 | −2.23 | 36.48 | 0.262 | −0.64 | 9.70 | −1.41 | 10.78 | −2.77 | 11.73 | 0.396 |
| ≥68 | 243 | 5.96 | 42.21 | −2.06 | 46.74 | −9.68 | 57.35 | 0.129 | 6.06 | 35.60 | 6.37 | 36.39 | −1.36 | 34.91 | 0.285 | −2.18 | 10.58 | −4.50∗ | 9.36 | −4.99 | 9.75 | 0.123 | |
| P-14 | <9 | 274 | −0.89 | 57.27 | −5.27 | 58.57 | −10.63 | 67.61 | 0.676 | 7.29 | 28.72 | 5.65 | 34.89 | −3.68 | 42.90 | 0.178 | −1.36 | 11.63 | −2.39 | 9.87 | −4.98 | 10.05 | 0.094 |
| ≥9 | 211 | 12.07 | 35.90 | −6.49 | 61.19 | −8.33 | 53.71 | 0.007 | 6.18 | 43.25 | 2.69 | 32.89 | −0.43 | 29.55 | 0.428 | −1.35 | 9.20 | −3.36 | 10.40 | −3.27 | 11.17 | 0.24 | |
P-14: 14-point Mediterranean diet score test; GLU: glucose; TG: triglycerides; DBP: diastolic blood pressure.
a P value tested by ANOVA.
Values with asterisks are statistically different from the baseline by the paired-samples t-test (∗ P < 0.05; ∗∗ P < 0.01).